Kim Iversen, a popular political talk show host with over 27K followers on Twitter, claimed that people who are fully vaccinated against COVID-19 are global superspreaders of the new omicron variant. “I can’t believe that after fully vaccinated travelers have been found to be the global spreaders of the omicron variant, we’re STILL talking about forcing people into being vaccinated,” she wrote on Twitter. We find this claim to be misleading. There is very little data on how the new variant is being spread.
November 18, 2021 – Chulalongkorn University held Chula The Impact 5 Seminar on “The Progress on ChulaCov19 — an mRNA vaccine by Thais — the World’s Hope“. Also discussed was the progress of Chula-Baiya, Thailand’s first protein subunit vaccine from tobacco leaves by Baiya Phytofarm Co., Ltd., and Faculty of Pharmaceutical Sciences, Chulalongkorn University.
A new opinion piece published online in the Annals of the American Thoracic Society provides an exhaustive examination of the ethics of using hospital resources on unvaccinated-by-choice COVID-19 pneumonia patients, versus patients with other serious illnesses whose diseases are not progressing as quickly.
Just as families are making holiday plans and vaccines are rolling out for children ages 5 to 11, the world is suddenly on high alert about Omicron, a new coronavirus variant that is circulating around the globe.
Patients whose immune systems are weakened due to cancer, organ or bone marrow transplants, chronic diseases, or the medications used to treat these conditions may feel like they have enough on their plates without worrying about whether and when they should take an additional dose of COVID-19 vaccine and a flu shot.
Dec. 1, 2021— People living with HIV experience more severe outcomes and have higher comorbidities from COVID-19 than people not living with HIV, according to the 2020 UNAIDS Global Update. In mid-2021, most people living with HIV did not have access to COVID-19 vaccines. This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on governments, health advocates and non-government organisations to strengthen their response to AIDS and COVID-19 by making COVID-19 vaccines more accessible worldwide.
Mount Sinai researchers have delineated four new subgroups of COVID-19 that can be identified in patients within 24 hours of admission to the intensive care unit (ICU). The finding will help match patients to specific treatments, improving their overall care and outcomes.
The reason some people get COVID-19, face hospitalization and die may have more to do with underlying health conditions, where they were born, live and work, and their access to testing and care, according to a new Rutgers study.
The Duke Clinical Research Institute (DCRI), Center for Health Equity Research at UNC-Chapel Hill (UNC-CHER), and Community-Campus Partnerships for Health (CCPH) today announced plans to deliver their You & Me COVID-Free testing project in Merced County, Calif., in partnership with United Way.
The Icahn School of Medicine at Mount Sinai will serve as a hub site for two cohort studies contributing to a nationwide health consortium study by the National Institutes of Health (NIH) on the long-term effects of SARS-CoV-2, the virus that causes COVID-19.
Rutgers, a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children, is looking for participants for a third clinical trial on children ages 6 months to 4 years.
A new article published in The New England Journal of Medicine suggests that secondary antibodies known as “anti-idiotype antibodies” could be responsible for some of the side effects of COVID-19 vaccines and the symptoms of long-haul COVID.
In a collaborative study, Cleveland Clinic researchers sought to understand how COVID-19 infection affects pregnant mothers and their children. They published the results of their clinical study in Cell Reports Medicine.
According to a study from the University of Illinois Chicago, adding a small amount of hydrogen peroxide to the water in ultrasonic scalers used to clean teeth can help mitigate the risk of spreading airborne diseases, including COVID-19, in clinical dental environments.
In the early stages of the COVID-19 pandemic, while many of us remained in the safety of our own homes, frontline healthcare workers faced a sudden influx of patients with the new, highly contagious, life-threatening disease.
Paul Marik, MD, one of the world’s leading critical care physicians and the Director of the ICU at Sentara Norfolk General Hospital, part of Sentara Healthcare, was in a Virginia courtroom fighting to treat critically ill COVID-19 patients while his employer was placing a letter notifying him of suspension of hospital privileges on his desk in his hospital office.
In May 2021, the Centers for Disease Control officially recognized that SARS-CoV-2 is airborne. Now UC San Diego Professor Rommie Amaro has modeled the delta virus inside an aerosol for the first time.
COVID-19 saliva testing kits that include a novel preservative can also be used measure microscopic organisms in the mouth, a Rutgers study found. This enables study of the relationship between mouth and lung microbes and the SARS-CoV-2 virus that may allow for the development of new treatments.
Efforts from West Virginia University's School of Public Health to help track the spread of COVID-19 through contact tracing, mapping, wastewater monitoring and more played a pivotal role in West Virginia’s response to the pandemic. Yet, work by faculty members also emphasized the need for public and private investments in research, training and infrastructure to ensure better delivery of health care and save lives in the future.
While cases appear to have fallen in Uttar Pradesh as well as most locations in India, it’s not clear why. Many other factors, including immunity from a previous infection, vaccination, and lockdowns, likely helped reduce the number of cases.
Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal membrane oxygenation (ECMO) therapy – with no increased risk of transmitting COVID-19 transmission to ECMO transport team members following standard precautions, reports a study in the ASAIO Journal, official journal of the American Society for Artificial Internal Organs. The journal is published in the Lippincott portfolio by Wolters Kluwer.
An unborn baby could become infected with Covid-19 if their gut is exposed to the SARS-CoV-2 virus, finds a new study led by UCL researchers with Great Ormond Street Hospital for Children and the NIHR Great Ormond Street Biomedical Research Centre.
A plant-based antiviral treatment for Covid-19, recently discovered by scientists at the University of Nottingham, has been found to be just as effective at treating all variants of the virus SARS-CoV-2, even the highly infectious Delta variant.
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer's COVID-19 vaccine, according to a study from Washington University School of Medicine in St. Louis. A third vaccine dose drove antibody levels back up, indicating that this additional dose may provide protection as the virus's delta variant continues to spread.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) conducted a head-to-head test of the second-generation vaccine CV2CoV compared with CVnCoV. The scientists assessed the vaccines’ ability to provoke an immune response as well as their protective efficacy against COVID-19 in non-human primates.
Nearly one in three older adults plans a long trip far from home in the next year, and many look forward to holiday travel in the next two months, a new poll finds. But many said they would consider local COVID-19 case rates at their destination.
Two genetic risk variants that are carried by nearly 40 percent of Black individuals may exacerbate the severity of both sepsis and COVID-19, a team of researchers from the University of Pennsylvania’s Perelman School of Medicine have found.
When a team of doctors, scientists and engineers at Addenbrooke’s Hospital and the University of Cambridge placed an air filtration machine in COVID-19 wards, they found that it removed almost all traces of airborne SARS-CoV-2.
The study found that overall, hospitalized COVID-19 patients taking immunosuppressive drugs did not face increased risk of death or being put on a ventilator compared with non-immunosuppressed hospitalized COVID-19 patients.
New research from McMaster University, aimed at understanding the immune response to COVID-19 vaccines, found some long-term care residents no longer had high antibody levels months after their second dose, directly supporting government decisions to provide third doses.
Binghamton University Chemistry Professor Eriks Rozners has received a two-year $428,330 grant from the National Institute of Allergy and Infectious Diseases for a research project which explores the "switch" behind the coronavirus.